Kheiron Company

At Kheiron, we are going where only a few have gone before; seeking a new understanding of cancer and how to detect it using artificial intelligence and human insight. We’ve made significant breakthroughs with our breast cancer screening product Mia but this is just the beginning of our journey. Ultimately we want to radically improve the outcomes for cancer patients by pioneering a new era of, what we call, precision radiology. While this all sounds very serious and it is, we believe in having fun along the way. Karaoke is our favourite sport. We also have an incredible crew from more than twenty different countries and offices in London, Budapest, Amsterdam and San Francisco. Giving every woman a better fighting chance against cancer.


Connections from

Technology: Biomarkers of Female Cancers
Industry: Healthcare
Headquarters: London, England, United Kingdom
Founded Date: 2016
Employees Number: 1-10
Funding Status: Series A
Investors Number: 18
Total Funding: $22 M
Estimated Revenue: $10M to $50M

Visit Website
Register and Claim Ownership